DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. - Wikidata - awgldk - TriplyDB

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

http://www.wikidata.org/entity/Q34206957

about

Twenty Years of PSA: From Prostate Antigen to Tumor Marker A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer Circulating long non-coding RNAs in cancer: current status and future perspectives PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Virus encoded circulatory miRNAs for early detection of prostate cancer Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis Landmarks in prostate cancer diagnosis: the biomarkers Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel Urinary biomarkers for prostate cancer How Precisely Can Prostate Cancer Be Managed?Molecular markers in prostate cancer. Part I: predicting lethality.A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.Long Noncoding RNAs as Biomarkers in Cancer.Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.Proteomics in prostate cancer biomarker discovery.Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score.Noncoding RNAs as novel biomarkers in prostate cancer.Novel diagnostic biomarkers for prostate cancer.PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer.PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.Can urinary PCA3 supplement PSA in the early detection of prostate cancer?Progensa PCA3 test for prostate cancer detection.Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.The functional role of long non-coding RNA in human carcinomas.MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates Genes differentially expressed in prostate cancer.Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer Applicability of biomarkers in the early diagnosis of prostate cancer.

P2860

Q24564782-767113E9-2666-49C2-8AAA-D8D39609D0E8 Q24569630-35A621B4-A3AD-4C80-8C23-FA5CE49771C1 Q24606772-EE8B4367-88BB-424E-A332-BB460B69537E Q24629083-B1257C79-3C9B-4AB7-86CD-D8C236E76F2F Q24649955-88793D84-B5F2-41EB-9EAB-09292319A39C Q26748862-589FB4A2-6E4E-4F15-A8F6-CBCC610835E9 Q26752933-0BDA8EF3-7AA9-4E43-AC1E-03DE5F24C38B Q26767044-393AE94B-E512-4B68-95D2-435239693026 Q26774456-8961A702-25D0-45F5-B54C-9A7AE4230436 Q26776424-81834749-2915-4455-A032-D94639EACE10 Q26800873-B19FD142-3F04-422A-A786-106990BF3DAD Q26852523-CD65C55A-A1AF-4B8C-8EBE-5BC4022E0531 Q27001399-0DB85763-2EBA-4810-96A5-CC0F413FA5CB Q27009110-AEECA09F-AE29-4896-9E33-FDFAF9082533 Q28078942-1F6AE80C-5C9C-44A8-A4D0-DA5C8BC1CA0F Q30373669-214CC9DA-F33B-41EF-93E0-DBD52D7389F6 Q33381646-BC812978-7725-4DBA-9271-23B3A27C5D37 Q33786847-559A69EA-8AE5-4184-8767-554CA3D77159 Q33948361-5ACE61C3-C400-4284-89F3-0F7B13943CE4 Q34096086-AD1EC09C-0061-4971-AD90-1CA2AF3B9513 Q34130249-C78F74B8-6D73-48A6-ADBF-E1CFE2360666 Q34176890-4982C4B9-5E32-45DA-BF0F-209BB1E2C39B Q34231678-8DBB64C3-99B4-4A25-BE6E-89A900C3FF72 Q34457066-C22BF849-C8BB-46FA-8F28-0ED8FC2E9BF4 Q34468270-D28518F2-4401-44A3-B975-FD7E15599B2C Q34536729-E397F7ED-550D-4874-80C8-6D4123692EEC Q34692263-EF344149-2C81-41CC-A1E8-42F22A8B6A35 Q34692442-5C7D10CB-B659-4916-AFAF-278AC659CFD7 Q34805223-3AD9467D-8E5A-46AF-9B01-22B32BBAD19E Q34984413-5F7DA46D-35C4-402E-89C0-956863FAF137 Q34995156-8ABBF51C-0BD4-4681-B372-1B7E56F93077 Q35014089-368BB26C-74A1-4679-90D8-A3E3367E078F Q35074229-0B00D9F3-5E1A-4B94-B1DA-19239D0C3729 Q35140145-B9D12B5A-1C0B-43C6-B9C7-27ED68A29A70 Q35148262-560432AE-53DD-4FA0-B8D2-F0FAD1A9FBA7 Q35154249-24DAABA6-09C4-4F29-A6C7-72BE902CE378 Q35751842-28BEFD90-5143-400D-9D98-80848C011F6E Q35772604-B5A1E2BE-131F-4E4C-8859-C231ED6C24CE Q35814012-DD32DFDD-EFCE-41CC-B20E-D0C2D1895CC2 Q35821838-ABD0A89B-709B-438D-89E5-AC54938BD849

P2860

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

http://www.wikidata.org/entity/Q34206957

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

DD3

@nl

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@ast

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@en

type

label

DD3

@nl

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@ast

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@en

altLabel

DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

@en

prefLabel

DD3

@nl

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@ast

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@en

P1433

Q34206957-139ACC03-D683-405C-A540-47358AF04F30

P1476

Q34206957-6AB15030-A181-45BE-BF25-B6340E4FB4FF

P2093

Q34206957-0C95DAA2-77D4-471E-AC94-70D107AF6D1B

Q34206957-2821B537-7C6D-4833-B357-5983D86BEC17

Q34206957-7971743E-5B5B-4F5C-8A20-BE3EF6E1A847

Q34206957-886466E8-39E6-476E-A98F-AEF3396F3198

Q34206957-98F68A21-4C94-435D-93F2-111890F776F6

Q34206957-A3AD05A0-7559-4B1C-8AC6-58F6BF601AB0

Q34206957-D8E1C23E-661B-49F1-8C50-06CE7FD39FF3

Q34206957-E0264A1E-CCF1-4F1B-9811-A1CA210E0B64

P304

Q34206957-9F2A7C2D-EC58-4C7A-8587-DC31FF311C4C

P31

Q34206957-1894130E-D43B-448D-9F1B-8C36C2BC7BA5

P356

Q34206957-9E11F20D-07C8-4629-8F1B-F1501F606637

P407

Q34206957-121B4774-29EE-4D4A-96DB-0600DB52889B

P433

Q34206957-34D6677F-643A-4630-A588-7D22783B5286

P478

Q34206957-846482DA-C7F8-4525-A7AA-E2B6DC256546

P50

Q34206957-91F306D9-59F7-4A13-90BE-CD62F0767356

P577

Q34206957-12ACE9F6-A079-4F3A-8504-355D896CEFFD

P698

Q34206957-77AF7BF2-6500-4346-8DAF-03B5154F0328

P356

S0302-2838(03)00201-X

P1433

European Urology

P1476

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@en

P2093

Bianca van Balken

http://www.w3.org/2001/XMLSchema#string

Daphne Hessels

http://www.w3.org/2001/XMLSchema#string

Geert J L van Leenders

http://www.w3.org/2001/XMLSchema#string

Herbert F M Karthaus

http://www.w3.org/2001/XMLSchema#string

Inge van Oort

http://www.w3.org/2001/XMLSchema#string

J Alfred Witjes

http://www.w3.org/2001/XMLSchema#string

Jack A Schalken

http://www.w3.org/2001/XMLSchema#string

Jacqueline M T Klein Gunnewiek

http://www.w3.org/2001/XMLSchema#string

P304

8-15; discussion 15-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0302-2838(03)00201-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Lambertus Kiemeney

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12814669

http://www.w3.org/2001/XMLSchema#string